A new FDA-approved blood test for Alzheimer disease could transform diagnosis and treatment accessibility, according to this conversation with Howard Fillit, MD, and Anthony “Nino” Sireci, MD, MSc.
Howard Fillit, MD
Advertisement
Articles by Howard Fillit, MD
Advertisement
Latest Updated Articles
- Opportunities for Improving Managed Care for Individuals with Dementia: Part I - The Issues
Published: March 1st 1999 | Updated:
- Opportunities for Improving Managed Care for Individuals with Dementia: Part II - A Framework for Care
Published: March 1st 1999 | Updated:
- The Pharmacoeconomics of Alzheimer's Disease
Published: December 1st 2000 | Updated:
- Managed Care Decisions in Alzheimer's Disease
Published: December 1st 2000 | Updated:
- Use of Ineffective or Unsafe Medications Among Members of a Medicare HMO Compared to Individuals in a Medicare Fee-for-Service Program
Published: April 1st 1997 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Medicaid Work Requirements Set to Leave Millions Without Insurance
2
Most Favored Nation Drug Pricing Moves Forward, but Experts Warn Details Are Still Missing
3
AMCP Nexus 2025: Advancing Health Policy and Patient Outcomes Together
4
Oncology Landscape Continues to Evolve With Expanded Indications, First-in-Class Therapies
5
